Showing results (1-10 of 80) with videos related to
Sort By:
Pageof 8
Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2006
Rational use of cytotoxic chemotherapy for recurrent ovarian cancerJoyce Liu, Ursula MatulonisTherapeutic Advances in Medical Oncology|May 12, 2017
PARP inhibitors in ovarian cancer: evidence, experience and clinical potentialTarra Evans, Ursula MatulonisGynecologic Oncology|April 19, 2019
Immunotherapy and radiation combinatorial trials in gynecologic cancer: A potential synergy?Larissa Lee, Ursula MatulonisJournal of the National Comprehensive Cancer Network : JNCCN|September 3, 2016
Next-Generation Sequencing: Role in Gynecologic CancersTarra Evans, Ursula MatulonisGynecologic Oncology|January 26, 2018
The NCI-MATCH trial and precision medicine in gynecologic cancersLisa Barroilhet, Ursula MatulonisGynecologic Oncology|February 4, 2018
Management of the toxicities of common targeted therapeutics for gynecologic cancersCamille C Gunderson, Ursula Matulonis, Kathleen N MooreGynecologic Oncology|October 4, 2011
The importance of chemotherapy and radiation in uterine papillary serous carcinomaAkila N Viswanathan, Eric A Macklin, Ross Berkowitz, et al.Gynecologic Oncology|November 12, 2013
Clinical predictors of long-term survival for stage IVB uterine papillary serous carcinoma confined to the abdomenLarissa J Lee, Rebecca Demaria, Ross Berkowitz, et al.Breast (Edinburgh, Scotland)|October 29, 2005
Metaplastic carcinoma of the breast with neuroglial differentiationMehra Golshan, Adam Kuten, Jacquleine William, et al.Case Reports in Hematology|October 23, 2018
Multiple Myeloma Masquerading as Ovarian Carcinosarcoma Metastases: A Case Report and Review of the Approach to Multiple Myeloma Screening and DiagnosisRobert Stuver, Alec Petersen, Thomas A Guerrero-Garcia, et al.Pageof 8